Literature DB >> 3171620

Motor neuron disease and malignancies: results of a population-based study.

A Chiò1, F Brignolio, P Meineri, M G Rosso, A Tribolo, D Schiffer.   

Abstract

Eight cases of malignancies with concurrent motor neuron disease (MND), derived from an unselected population representing all cases of MND diagnosed during a 15-year period in two Italian provinces, were studied to verify the existence of paraneoplastic forms of the disease. No statistically significant association between the two diseases was found. Therefore, from our findings the occurrence of a neoplasm in a patient affected by MND can be considered a chance association.

Entities:  

Mesh:

Year:  1988        PMID: 3171620     DOI: 10.1007/bf00314238

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  Epidemiology of motor neuron disease in two Italian provinces. Analysis of secular trend and geographic distribution.

Authors:  A Chiò; F Brignolio; P Meineri; M G Rosso; D Schiffer
Journal:  Neuroepidemiology       Date:  1989       Impact factor: 3.282

Review 2.  Motor neuron disease: changing population patterns and clues for etiology.

Authors:  K Kondo
Journal:  Adv Neurol       Date:  1978

3.  Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease).

Authors:  L Brain; P B Croft; M Wilkinson
Journal:  Brain       Date:  1965-09       Impact factor: 13.501

4.  Motor neuron disease with renal cell carcinoma and postoperative neurologic remission. A clinicopathologic report.

Authors:  D S Buchanan; N Malamud
Journal:  Neurology       Date:  1973-08       Impact factor: 9.910

5.  Computing man years at risk.

Authors:  I D Hill
Journal:  Br J Prev Soc Med       Date:  1972-05

6.  A study of the effects upon the motor unit by remote malignancy.

Authors:  G M Shy; I Silverstein
Journal:  Brain       Date:  1965-09       Impact factor: 13.501

7.  Geographic distribution of motor neuron disease and correlation with possible etiologic factors.

Authors:  N E Bharucha; B S Schoenberg; R H Raven; L W Pickle; D P Byar; T J Mason
Journal:  Neurology       Date:  1983-07       Impact factor: 9.910

8.  The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients.

Authors:  M Jokelainen
Journal:  J Neurol Sci       Date:  1976-09       Impact factor: 3.181

9.  Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

Authors:  S S Gubbay; E Kahana; N Zilber; G Cooper; S Pintov; Y Leibowitz
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

  9 in total
  7 in total

1.  Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease.

Authors:  Oliver Stich; Barbara Kleer; Sebastian Rauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-21       Impact factor: 10.154

2.  The association between cancer and amyotrophic lateral sclerosis.

Authors:  D Michal Freedman; Rochelle E Curtis; Sarah E Daugherty; James J Goedert; Ralph W Kuncl; Margaret A Tucker
Journal:  Cancer Causes Control       Date:  2012-10-23       Impact factor: 2.506

3.  The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study.

Authors:  D Michal Freedman; Jincao Wu; Sarah E Daugherty; Ralph W Kuncl; Lindsey R Enewold; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2014-02-28       Impact factor: 7.396

4.  Population-based risks for cancer in patients with ALS.

Authors:  Summer B Gibson; Diana Abbott; James M Farnham; Khanh K Thai; Hailey McLean; Karla P Figueroa; Mark B Bromberg; Stefan M Pulst; Lisa Cannon-Albright
Journal:  Neurology       Date:  2016-05-11       Impact factor: 9.910

5.  Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS.

Authors:  Harun Najib Noristani; Jean Charles Sabourin; Yannick Nicolas Gerber; Marisa Teigell; Andreas Sommacal; Maria dM Vivanco; Markus Weber; Florence Evelyne Perrin
Journal:  Mol Neurodegener       Date:  2015-08-01       Impact factor: 14.195

Review 6.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

7.  Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.

Authors:  Fang Fang; Ammar Al-Chalabi; Lars-Olof Ronnevi; Martin R Turner; Karin Wirdefeldt; Freya Kamel; Weimin Ye
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-03-26       Impact factor: 4.092

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.